ClinicalTrials.gg
BiologicalDrug

Axicabtagene ciloleucel clinical trials

Also written Yescarta® and KTE-C19.

studies test it
26
open now
10
in phase 3
4
first study started
2016

How each study uses axicabtagene ciloleucel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the axicabtagene ciloleucel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Oct 2017 · Yescarta · BLA 125643 (FDA, Purple Book)
European Union
23 Aug 2018 · Yescarta · EMEA/H/C/004480 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Axicabtagene Ciloleucel
24
Axi-cel
9
KTE C19
3
KTE-C19 CAR
3

Brand

Yescarta®
14

Development codes

KTE-C19
6
FKC-876
1

Studies by the year they started

26 studies that test it; most in 2023 (4)

Studies that test axicabtagene ciloleucel, by start year
YearStudies
20161
20171
20182
20192
20202
20212
20222
20234
20244
20253
20263

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
14
Phase 3
4
Phase 4
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 16

Kite, A Gilead Company (10) · Ruijin Hospital (2) · M.D. Anderson Cancer Center (2) · Stanford University (1) · Dana-Farber Cancer Institute (1) · The Lymphoma Academic Research Organisation (1) · Masonic Cancer Center, University of Minnesota (1) · Vanderbilt-Ingram Cancer Center (1)

Often tested with

Tested in the same studies.

Fludarabine (3) · Cyclophosphamide (3) · Tisagenlecleucel (2) · Lisocabtagene maraleucel (2) · Autologous Anti-CD19/Anti-CD20 CAR-T Cells KITE-753 (1) · Brexucabtagene autoleucel (1) · Idecabtagene vicleucel (1) · Rituximab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test axicabtagene ciloleucel.

Studies

Open first, then newest update. How each study uses axicabtagene ciloleucel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test axicabtagene ciloleucel →

Given beside what is tested · 15 — axicabtagene ciloleucel is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with axicabtagene ciloleucel

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call axicabtagene ciloleucel · ClinicalTrials.gg INT001010

  • MeSH (NLM) C000629083axicabtagene ciloleucelConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) U2I8T43Y7RAXICABTAGENE CILOLEUCELConfirmed FDA, NLM, Wikidata
  • RxNorm 1987398Confirmed FDA, Wikidata
  • Wikidata Q30314851axicabtagene ciloleucelConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C120309Axicabtagene CiloleucelOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.